Whilst e-Consent was permitted from a regulatory and ethical perspective previously, its use has increased more recently, not least due to the Covid-19 pandemic and the need to move some clinical trial processes remotely. Whilst there may be benefits to implementing e-Consent, it is not without challenges and as more people engage in implementing e-Consent, Trials is keen to share trialists’ experiences, innovations, case studies and methodological research into this emerging area.
This collection is no longer accepting submissions
Edited by:
Peter Jüni, MD, FESC, University of Oxford, United Kingdom
Tianjing Li, PhD, University of Colorado Denver, United States of America
Shaun Treweek, PhD, University of Aberdeen, United Kingdom